COL4A5 and hearing loss disorder: All patients clinically diagnosed with Alport syndrome also exhibited extrarenal manifestations, including sensorineural hearing loss, consistent with syndromic features of AS and supporting the pathogenic relevance of identified COL4A3 and COL4A5 variants.